The Zhitong Finance App learned that on October 23, the Hong Kong Stock Exchange launched its first artificial intelligence index. According to reports, the Hong Kong Stock Exchange Artificial Intelligence Index tracks the performance of 40 Hong Kong listed companies that are highly related to the AI industry chain, covering the five major fields of chip design, data centers, AI infrastructure, AI models, and software and physical applications. The first batch of 40 components included SMIC (00981), an established computing power hardware circuit, Smart Spectrum (02513) for the AI Big Model Circuit, and Universal Data-SW (09698) for the AI infrastructure circuit, as well as Jetai Technology-P (07666) in the AI pharmaceutical sector.
At present, Jietai Technology has opened up the entire chain of AI molecular design, RNA code optimization, and accurate LNP delivery to accurate clinical implementation. As a core enterprise on the global AI nano-delivery circuit, the company is expected to attract the passive capital layout of the tracking index, and at the same time place it at the center of vision for global investors to allocate Hong Kong's AI core assets.
Furthermore, recently, Jietai Technology officially announced that it has reached a cooperation with global pharmaceutical giant Lilly on the largest AI-driven extra-hepatic LNP delivery platform in the world. In this major strategic cooperation with a total cost of up to 1.1 billion US dollars, the two sides will focus on research and discovery of novel LNP (lipid nanoparticle) delivery solutions.
The positive news came on top of the catalyst for major commercial orders. Recently, Jetai Technology's stock price has continued to strengthen, rising more than 10% in the past 5 days. According to market analysts, Jietai Technology's first-mover advantage and platform-based monetization potential in the field of AI drug delivery have not yet been fully priced. With the gradual release of index fund allocation requirements and the continuous iteration of its self-developed Biological AI key infrastructure NanoForge platform, Jietai Technology is expected to take the lead in achieving valuation repair.